Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02606695 · ClinicalTrials.gov registry record
Comprehensive Spinal Alignment Planning Study
A clinical trial, sponsored by NuVasive.
- Completed
- Registry status
- 306
- Enrollment target
NCT02606695 is a clinical trial that has completed, run by NuVasive. The registered enrollment target is 306 participants.
The verdict
NCT02606695 has completed, sponsored by NuVasive.
- COMPLETED
- Registry status
- 306 participants
- Enrollment target
Study Summary
A comprehensive approach to the evaluation of alignment in spinal surgery patients - through preoperative planning, intraoperative assessment, and postoperative confirmation - has not been well-studied. This study aims to assess the value of such planning through clinical and radiographic outcomes.
Interventions
- DEVICE NuvaMap O.R.
- DEVICE NuvaMap
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2016-03 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02606695
The ClinicalTrials.gov registry entry for NCT02606695 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 306 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NuVasive, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NuvaMap O.R. is the first listed.
NCT02606695 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02606695 about?
NCT02606695 is a clinical study titled "Comprehensive Spinal Alignment Planning Study". A comprehensive approach to the evaluation of alignment in spinal surgery patients - through preoperative planning, intraoperative assessment, and postoperative confirmation - has not been well-studied. This study aims to assess the value of such planning through clinical and radiographic outcomes.
What is the current status of trial NCT02606695?
This trial is currently completed. The enrollment target is 306 participants. The study started on 2016-03. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT02606695?
The interventions under investigation include: NuvaMap O.R. (DEVICE), NuvaMap (DEVICE).
Who is sponsoring clinical trial NCT02606695?
This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.